We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

America’s Opioid Epidemic: Who Will Be Held Accountable?
  • Husch Blackwell LLP
  • USA
  • October 11 2017

In recent years America has seen an increasing number of opioid-involved deaths and is currently experiencing what the Center for Disease Control


FDA breaks with SBA on small business affiliation
  • Husch Blackwell LLP
  • USA
  • August 9 2017

Small business status impacts government contractors in several ways. Set-aside procurements and financial assistance programs are available for small


Food Safety Modernization Act Transportation Waivers Issued
  • Husch Blackwell LLP
  • USA
  • April 7 2017

Earlier this week, the FDA published three anticipated waivers to the Food Safety Modernization Act’s Sanitary Transportation of Human and Animal Food


SXSW 2017 -Dare Enter the World of the FDA?
  • Husch Blackwell LLP
  • USA
  • March 14 2017

The weather has cleared and SXSW is well underway! The HBInnovate team has been sharing its experiences via Twitter and blog, keeping everyone


Continued Coverage of the SXSW Interactive Conference, Health Track - Accuracy: Consumer Wearables and Academic Research
  • Husch Blackwell LLP
  • USA
  • March 13 2017

Given the transformations taking place at every level in healthcare, it is no surprise that the 2017 SXSW Interactive Conference has a big spotlight


Rep. Tom Price Confirmation Hearings - What we have learned
  • Husch Blackwell LLP
  • USA
  • January 30 2017

President Trump's nominee for Secretary of the Department of Health & Human Services (HHS), Congressman Tom Price (R-Ga.), has now completed two


What’s next for Trump’s HHS Secretary nominee?
  • Husch Blackwell LLP
  • USA
  • December 14 2016

One of President-elect Trump's many campaign promises included "repealing and replacing" the Affordable Care Act (ACA), known as Obamacare. Trump


Revised Cuba Rules Allow Medical Collaboration and Ease Some Trade
  • Husch Blackwell LLP
  • USA, Cuba
  • October 17 2016

The U.S. Department of Treasury’s Office of Foreign Assets Control (“OFAC”) and the U.S. Department of Commerce’s Bureau of Industry and Security


FDA Requires Highest Level of Warning on Opioids & Benzodiazepines
  • Husch Blackwell LLP
  • USA
  • September 12 2016

On August 31, 2016 the Food and Drug Administration (FDA) issued a new directive to include the “black box” label on approximately 400 opioid and


Industrial Hemp - Statement of Principles from USDA
  • Husch Blackwell LLP
  • USA
  • August 25 2016

The US Department of Agriculture provided statements of principals on industrial hemp, in consultation with the DEA and the FDA, to inform the public